Final Glance: Biotechnology companies
News | 31 July 2012
NEW YORK ? Shares of some top biotechnology companies were down at the close of trading: Amgen Inc. fell $.86 or 1.0 percent, to $82.60. Biogen Idec fell $1.45 or 1.0 percent, to $145.83. Celgene Corp. fell $.94 or 1.4 percent, to $68.46. Gilead ...
Click on the link to read the full article at CBS News
(This link will open in a new window)
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
